ADPT (STOCKS)
Adaptive Biotechnologies Corporation Common Stock
$24.460000
-0.790000 (-3.13%)
Prev close: $25.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Chad Robins
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,270.43M
- Employees
- 619
- P/E (TTM)
- -61.90
- P/B (TTM)
- 28.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.10 | $-0.14 | +0.0364 | +26.69% |
|
Mar 2026 (Q1)
|
$-0.12 | $-0.16 | +0.0432 | +26.47% |
|
Dec 2025 (Q4)
|
$-0.09 | $-0.18 | +0.0949 | +51.33% |
|
Sep 2025 (Q3)
|
$0.06 | $-0.15 | +0.2092 | +140.21% |
Financial Statements
| Revenues | $308.08M |
| Benefits Costs and Expenses | $372.07M |
| Cost Of Revenue | $75.25M |
| Costs And Expenses | $345.54M |
| Gross Profit | $232.83M |
| Operating Expenses | $270.29M |
| Research and Development | $88.21M |
| Other Operating Expenses | $171.07M |
| Operating Income/Loss | -$37.46M |
| Income/Loss From Continuing Operations After Tax | -$63.99M |
| Income/Loss From Continuing Operations Before Tax | -$63.99M |
| Interest Expense, Operating | $11.51M |
| Net Income/Loss | -$63.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$136.00K |
| Net Income/Loss Attributable To Parent | -$63.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$63.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.41 |
| Diluted Earnings Per Share | -$0.41 |
| Basic Average Shares | 468,282,153 |
| Diluted Average Shares | 479,011,953 |
| Assets | $640.68M |
| Current Assets | $420.56M |
| Inventory | $10.50M |
| Other Current Assets | $410.07M |
| Noncurrent Assets | $220.12M |
| Fixed Assets | $29.45M |
| Other Non-current Assets | $190.66M |
| Liabilities | $490.02M |
| Current Liabilities | $87.71M |
| Accounts Payable | $5.24M |
| Wages | $9.74M |
| Other Current Liabilities | $72.73M |
| Noncurrent Liabilities | $402.30M |
| Equity | $150.66M |
| Equity Attributable To Noncontrolling Interest | $7.75M |
| Equity Attributable To Parent | $142.91M |
| Liabilities And Equity | $640.68M |
| Net Cash Flow From Operating Activities | -$21.01M |
| Net Cash Flow From Operating Activities, Continuing | -$21.01M |
| Net Cash Flow From Investing Activities | -$25.30M |
| Net Cash Flow From Investing Activities, Continuing | -$25.30M |
| Net Cash Flow From Financing Activities | $173.03M |
| Net Cash Flow From Financing Activities, Continuing | $173.03M |
| Net Cash Flow | $126.72M |
| Net Cash Flow, Continuing | $126.72M |
| Comprehensive Income/Loss | -$64.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$136.00K |
| Comprehensive Income/Loss Attributable To Parent | -$64.14M |
| Other Comprehensive Income/Loss | -$285.00K |
| Other Comprehensive Income/Loss Attributable To Parent | -$285.00K |